205 related articles for article (PubMed ID: 37863710)
21. Cancer testis antigen PRAME: An anti-cancer target with immunomodulatory potential.
Naik A; Thomas R; Al-Khadairi G; Bacha R; Hendrickx W; Decock J
J Cell Mol Med; 2021 Nov; 25(22):10376-10388. PubMed ID: 34612587
[TBL] [Abstract][Full Text] [Related]
22. Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy.
Qin Y; Bollin K; de Macedo MP; Carapeto F; Kim KB; Roszik J; Wani KM; Reuben A; Reddy ST; Williams MD; Tetzlaff MT; Wang WL; Gombos DS; Esmaeli B; Lazar AJ; Hwu P; Patel SP
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33203661
[TBL] [Abstract][Full Text] [Related]
23. Association of Ultrasound Features in Uveal Melanoma With Metastatic Risk as Defined by Preferentially Expressed Antigen in Melanoma Status.
Rusakevich AM; Schefler AC; Zhou B; Brown A; Robe C; Bretana ME
Ophthalmic Surg Lasers Imaging Retina; 2022 Jul; 53(7):374-378. PubMed ID: 35858230
[TBL] [Abstract][Full Text] [Related]
24. Identification of survival-related genes and a novel gene-based prognostic signature involving the tumor microenvironment of uveal melanoma.
Lei S; Zhang Y
Int Immunopharmacol; 2021 Jul; 96():107816. PubMed ID: 34162166
[TBL] [Abstract][Full Text] [Related]
25. Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations.
Liu XL; Run-Hua Z; Pan JX; Li ZJ; Yu L; Li YL
Pigment Cell Melanoma Res; 2024 May; 37(3):411-425. PubMed ID: 38411373
[TBL] [Abstract][Full Text] [Related]
26. Genetic prognostication in uveal melanoma.
Dogrusöz M; Jager MJ
Acta Ophthalmol; 2018 Jun; 96(4):331-347. PubMed ID: 29105334
[TBL] [Abstract][Full Text] [Related]
27. Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment.
Gezgin G; Dogrusöz M; van Essen TH; Kroes WGM; Luyten GPM; van der Velden PA; Walter V; Verdijk RM; van Hall T; van der Burg SH; Jager MJ
Cancer Immunol Immunother; 2017 Jul; 66(7):903-912. PubMed ID: 28391358
[TBL] [Abstract][Full Text] [Related]
28. Additive Role of Immune System Infiltration and Angiogenesis in Uveal Melanoma Progression.
García-Mulero S; Alonso MH; Del Carpio LP; Sanz-Pamplona R; Piulats JM
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800878
[TBL] [Abstract][Full Text] [Related]
29. The immune cell landscape of metastatic uveal melanoma correlates with overall survival.
Tosi A; Cappellesso R; Dei Tos AP; Rossi V; Aliberti C; Pigozzo J; Fabozzi A; Sbaraglia M; Blandamura S; Del Bianco P; Chiarion-Sileni V; Rosato A
J Exp Clin Cancer Res; 2021 May; 40(1):154. PubMed ID: 33947438
[TBL] [Abstract][Full Text] [Related]
30. Liver metastasis in uveal melanoma - treatment options and clinical outcome.
Kaštelan S; Mrazovac Zimak D; Ivanković M; Marković I; Gverović Antunica A
Front Biosci (Landmark Ed); 2022 Feb; 27(2):72. PubMed ID: 35227015
[TBL] [Abstract][Full Text] [Related]
31. Intrinsic disorder in PRAME and its role in uveal melanoma.
Antonietti M; Gonzalez DJT; Djulbegovic M; Dayhoff GW; Uversky VN; Shields CL; Karp CL
Cell Commun Signal; 2023 Aug; 21(1):222. PubMed ID: 37626310
[TBL] [Abstract][Full Text] [Related]
32. An update on inflammation in uveal melanoma.
Liau S; Wang JZ; Zagarella E; Paulus P; Dang NHQH; Rawling T; Murray M; Zhou F
Biochimie; 2023 Sep; 212():114-122. PubMed ID: 37105300
[TBL] [Abstract][Full Text] [Related]
33. Novel prognostication biomarker adipophilin reveals a metabolic shift in uveal melanoma and new therapeutic opportunities.
Matareed M; Maranou E; Koskela SA; Mehmood A; Kalirai H; Coupland SE; Figueiredo CR
J Pathol; 2023 Jun; 260(2):203-221. PubMed ID: 36825655
[TBL] [Abstract][Full Text] [Related]
34. VISTA+/CD8+ status correlates with favorable prognosis in Epithelial ovarian cancer.
Jlassi A; Manai M; Morjen M; Sahraoui G; Elasmi Allal M; ELBini-Dhouib I; Naija L; Charfi L; Rejaibi R; Ben Ahmed M; Marrakchi N; Srairi-Abid N; Mezlini A; Manai M; Mrad K; Doghri R
PLoS One; 2023; 18(3):e0278849. PubMed ID: 36952478
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA expression analysis and Multiplex ligation-dependent probe amplification in metastatic and non-metastatic uveal melanoma.
Larsen AC; Holst L; Kaczkowski B; Andersen MT; Manfé V; Siersma VD; Kolko M; Kiilgaard JF; Winther O; Prause JU; Gniadecki R; Heegaard S
Acta Ophthalmol; 2014 Sep; 92(6):541-9. PubMed ID: 24373459
[TBL] [Abstract][Full Text] [Related]
36. Nestin expression in primary and metastatic uveal melanoma - possible biomarker for high-risk uveal melanoma.
Djirackor L; Shakir D; Kalirai H; Petrovski G; Coupland SE
Acta Ophthalmol; 2018 Aug; 96(5):503-509. PubMed ID: 29338117
[TBL] [Abstract][Full Text] [Related]
37. Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours.
Johansson PA; Brooks K; Newell F; Palmer JM; Wilmott JS; Pritchard AL; Broit N; Wood S; Carlino MS; Leonard C; Koufariotis LT; Nathan V; Beasley AB; Howlie M; Dawson R; Rizos H; Schmidt CW; Long GV; Hamilton H; Kiilgaard JF; Isaacs T; Gray ES; Rolfe OJ; Park JJ; Stark A; Mann GJ; Scolyer RA; Pearson JV; van Baren N; Waddell N; Wadt KW; McGrath LA; Warrier SK; Glasson W; Hayward NK
Nat Commun; 2020 May; 11(1):2408. PubMed ID: 32415113
[TBL] [Abstract][Full Text] [Related]
38. Role of immune checkpoint inhibitors and novel immunotherapies in uveal melanoma.
Jindal V
Chin Clin Oncol; 2018 Feb; 7(1):8. PubMed ID: 29486567
[TBL] [Abstract][Full Text] [Related]
39. BAP1 germline mutation in two first grade family members with uveal melanoma.
Maerker DA; Zeschnigk M; Nelles J; Lohmann DR; Worm K; Bosserhoff AK; Krupar R; Jägle H
Br J Ophthalmol; 2014 Feb; 98(2):224-7. PubMed ID: 24187051
[TBL] [Abstract][Full Text] [Related]
40. Two Pyroptosis-Related Subtypes with Distinct Immune Microenvironment Characteristics and a Novel Signature for Predicting Immunotherapy Response and Prognosis in Uveal Melanoma.
Lei S; Li H
Curr Eye Res; 2022 Jun; 47(6):930-943. PubMed ID: 35348009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
